CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1

Pancreatic cancer (PC) has a high degree of malignancy and poor prognosis, and countless patients have distant metastasis when diagnosed. Gemcitabine (GEM) chemotherapy is one of the main ways of treatment. However, PC cells have been displayed chemoresistance to GEM during treatment. Circular RNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yeting, Zhou, Shuping, Cheng, Gong, Ruan, Yi, Tian, Yuan, Lv, Kaiji, Han, Shuo, Zhou, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433304/
https://www.ncbi.nlm.nih.gov/pubmed/36059806
http://dx.doi.org/10.1155/2022/1911592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433304/
https://www.ncbi.nlm.nih.gov/pubmed/36059806
http://dx.doi.org/10.1155/2022/1911592

Ejemplares similares